by: Jeffry A. Siegel, Ph.D. and Richard B. Sparks, Ph.D.
1. Objectives
2. Abstract
3. Introduction
4. New NRC Regulations: Revised 10 CFR 35.75
5. NRC Default Tables
6. Patient-Specific Dose Calculation
7. Patient-Specific Dose Calculations Versus NRC Default Tables for Patient Release
8. Release of Patients Administered I-131 For Treatment of Thyroid Cancer and Hyperthyroidism
9. Release of Patients Administered I-131-Labeled Antibodies for Cancer Treatment
10. Expected Biologic Effects to Exposed Individuals From a Released Radionuclide Therapy Patient
11. Discussion
12. References
13. Test
